Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis
Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis
复制标题
DOI:
10.3748/wjg.v12.i28.4578
复制
发表时间:
2006-07-28
影响因子:
4.3
通讯作者:
Yong-Tang Feng
中科院分区:
文献类型:
--
作者:
Hao Yuan;Wan-Sheng Ji;Yong-Tang Feng
AIM: To explore the anti-inflammatory mechanism of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis induced by acetic acid.METHODS: Spragur-Dawley female rats were divided into four groups: Diammonium Glycyrrhizinate group, dexamethasone group, acetic acid control and normal control group. Colonic inflammation was evaluated by disease activity index, gross morphologic damage, histological injury and colonic myeloperoxidase activity. Immunohistochemistry was used to detect the expression of NF-kappa B, TNF-alpha and ICAM-1 in colonic mucosa.RESULTS: Compared to the acetic acid control, both Diammonium Glycyrrhizinate and dexamethasone showed a significant anti-inflammatory effect (P < 0.01). The expression of NF-kappa B, TNF-alpha and ICAM-1 in colonic mucosa was significantly lower in the Diammonium Glycyrrhizinate group and dexamethasone group than in the acetic acid group.CONCLUSION: Diammonium Glycyrrhizinate could reduce inflammatory injury in a rat model of ulcerative colitis. This may occur via suppression of NF-kappa B, TNF-alpha and ICAM-1 in colonic mucosa. (C) 2006 The WJG Press. All rights reserved.